<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jacobson, Anne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Moskowitz, Samuel M.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Multidrug-Resistant Pulmonary Pathogens: Controlling a Major Public Health Risk</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">18-19</style></pages><abstract><style  face="normal" font="default" size="100%">Multidrug-resistant lung infections are increasingly common in vulnerable patient populations, including patients with tuberculosis and cystic fibrosis and the critically ill. This article discusses new approaches to the diagnosis and management of antibiotic-resistant pulmonary pathogens, including the use of first-line combination antibiotic therapy and novel drug delivery.</style></abstract><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>